Roche’s Virtual Hematology Investor Event
Roche has hosted a virtual event on 16th June 2024.
| Agenda | |
|---|---|
| Introduction | Bruno Eschli, Head of Investor Relations |
| STARGLO: Columvi-GemOx for R/R DLBCL - Results of a Global Randomized Ph III Trial | Jeremy Abramson, Massachusetts General Hospital Cancer Center, Boston, MA, USA |
| Roche Bispecific Antibodies in NHL | William Waas, Lifecycle Leader NHL Bispecific Program, Global Product Strategy |
| Hemlibra: Improving Patient Experience | Daud Chaudry, Lifecycle Leader Hemlibra Program, Global Product Strategy |
| Q&A |
Webinar Replay
Investors